Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010787
Filing Date
2025-05-15
Accepted
2025-05-15 15:33:03
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 803234
2 EX-31.1 ex31-1.htm EX-31.1 19607
3 EX-31.2 ex31-2.htm EX-31.2 14933
4 EX-32.1 ex32-1.htm EX-32.1 7413
  Complete submission text file 0001641172-25-010787.txt   5401625

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20250331.xsd EX-101.SCH 45486
6 XBRL CALCULATION FILE biaf-20250331_cal.xml EX-101.CAL 67780
7 XBRL DEFINITION FILE biaf-20250331_def.xml EX-101.DEF 201597
8 XBRL LABEL FILE biaf-20250331_lab.xml EX-101.LAB 427517
9 XBRL PRESENTATION FILE biaf-20250331_pre.xml EX-101.PRE 336682
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 715638
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41463 | Film No.: 25951992
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)